360° UPSC Mains Analysis

Under the Seventh Schedule of the Constitution, 'Education, including technical education, medical education and universities' falls under Entry 25 of the Concurrent List (List III), allowing both the Centre and States to legislate. However, 'Coordination and determination of standards in institutions for higher education' falls under Entry 66 of the Union List (List I), giving the Central Government (via NCISM and NCH) the primary authority to enforce uniform quality standards.

The quality deficit in AYUSH education poses a significant barrier to India's ambitions of exporting traditional medicine and positioning itself as a global hub for medical value travel (MVT). Substandard training and lack of evidence-based practice, as highlighted by the 41% low-grading of homoeopathy colleges, undermine international trust and limit the export potential of AYUSH services and pharmaceuticals to highly regulated markets like the EU and the US.

The rapid expansion of AYUSH medical education, with a 43% increase in permitted seats and a 25% increase in total admission capacity between 2021 and 2024, contributes to the tertiary sector's growth and human capital formation. However, persistent quality issues and regulatory non-compliance, such as the denial of permissions to 17 private Ayurveda colleges as of August 21, risk creating a sub-standard workforce, which could lead to long-term economic inefficiencies in healthcare delivery and drag down overall labor productivity. Additionally, the nearly sixfold increase in the Centre's AYURGYAN allocation represents a rising fiscal commitment to traditional medicine, which requires stringent oversight to ensure optimal return on public expenditure.

The tertiary sector, specifically the healthcare and higher education industries, is directly affected. The private sector dominates this expansion, accounting for 86% of Ayurveda and 85% of homoeopathy colleges in 2024. However, the National Commission for Homoeopathy (NCH) grading 41% of homoeopathy colleges in the lowest tier highlights a severe quality deficit that could undermine the credibility and market growth of the alternative medicine industry.

The expansion increases employment opportunities for AYUSH graduates and educators, but the prevalence of 'fictitious faculty' and substandard training threatens the wages and professional credibility of genuine practitioners. For consumers, poor quality control in AYUSH education leads to a high risk of ineffective or unsafe medical practices, increasing out-of-pocket health expenditures and disrupting local healthcare supply chains.

During the colonial era, the British administration systematically marginalized indigenous medical systems (Ayurveda, Unani, Siddha) in favor of Western biomedicine (allopathy). The Bhore Committee (1946) further entrenched this bias by recommending a health system built almost exclusively on modern medicine, dismissing traditional systems as unscientific. This created a long-standing institutional and regulatory divide, leaving traditional systems with fragmented educational standards and a lack of formal state patronage at the time of independence.

Post-independence, the government sought to integrate and standardize traditional medicine, starting with the Chopra Committee (1948) and the Dave Committee (1955), which recommended uniform education standards and separate regulatory councils. The Central Council of Indian Medicine (CCIM) was established under the IMCC Act, 1970, followed by the Central Council of Homoeopathy (CCH) in 1973 to regulate education. Mainstreaming of AYUSH gained momentum with the creation of the Department of Indian Systems of Medicine and Homoeopathy (ISM&H) in 1995 (renamed AYUSH in 2003) and its elevation to a full Ministry in 2014. Finally, in 2020, the government replaced the legacy councils with the National Commission for Indian System of Medicine (NCISM) and the National Commission for Homoeopathy (NCH) to address persistent governance and quality issues.

The rapid, unregulated expansion of private AYUSH colleges in the 2020s closely parallels the boom of private engineering colleges in the early 2000s and private allopathic medical colleges in the 1990s. In both cases, commercial incentives led to a proliferation of institutions with severe infrastructure deficits, ghost faculty, and compromised educational quality, eventually forcing the Supreme Court and regulators (like the AICTE and MCI) to intervene with stringent compliance norms.

During the Swadeshi Movement (1905 onwards), the revival of indigenous medicine (Ayurveda and Unani) was championed as a form of cultural nationalism and self-reliance (Atmanirbharta) against British cultural hegemony. Leaders like Mahatma Gandhi and institutions like the Banaras Hindu University (BHU) advocated for the integration of traditional systems into national education to reclaim India's scientific heritage.

This issue directly compromises the right to health and dignity of patients who receive treatment from inadequately trained practitioners, potentially leading to misdiagnoses or worsening health conditions. For families of students, it results in severe financial distress as they invest their life savings or take loans for degrees that offer poor career prospects due to the low quality of institutional training. It also erodes public trust in traditional Indian knowledge systems, which are vital for holistic community well-being.

The issue directly implicates Article 21 of the Constitution of India, as the Supreme Court has repeatedly held that the 'Right to Health' is an integral part of the Right to Life, which is violated when citizens are treated by poorly trained medical professionals. It also relates to Article 47 (Directive Principles of State Policy), which mandates the State to improve public health as among its primary duties. Furthermore, it violates the right to quality education under the spirit of Article 21A, as students are defrauded by institutions lacking basic infrastructure and faculty.

As a District Magistrate, I would face the ethical conflict of 'Development vs. Regulation': balancing the promotion of traditional medicine systems and local educational infrastructure against the strict enforcement of standards that could lead to the closure of colleges and jeopardize students' careers. Additionally, there is a conflict between 'Profit-Maximization vs. Public Welfare', where private entities exploit regulatory loopholes for financial gain at the cost of public health and the right to quality education.

The rapid, commercialized expansion of private AYUSH colleges disproportionately impacts students from middle-class and Economically Weaker Sections (EWS) who face financial exploitation through high fees for substandard education. Furthermore, rural, tribal, and marginalized populations, who heavily rely on AYUSH practitioners due to the acute shortage of allopathic doctors in primary health centers, are subjected to substandard healthcare delivered by poorly trained graduates.